Chen‐Chung Chu

964 total citations
30 papers, 685 citations indexed

About

Chen‐Chung Chu is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Chen‐Chung Chu has authored 30 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 8 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Chen‐Chung Chu's work include T-cell and B-cell Immunology (9 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (6 papers). Chen‐Chung Chu is often cited by papers focused on T-cell and B-cell Immunology (9 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (6 papers). Chen‐Chung Chu collaborates with scholars based in Taiwan and United States. Chen‐Chung Chu's co-authors include Marie Lin, Yann‐Jinn Lee, Hsin‐Fu Liu, Tzu‐Yang Chang, Yuh‐Cheng Yang, Wei‐Shiung Yang, Pei‐Lung Chen, Cathy S.J. Fann, Chien-Ching Chang and Tien‐Chun Chang and has published in prestigious journals such as Nature Communications, PLoS ONE and Journal of Virology.

In The Last Decade

Chen‐Chung Chu

30 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chen‐Chung Chu Taiwan 18 288 193 140 134 126 30 685
Marta Zelazko Argentina 15 390 1.4× 106 0.5× 198 1.4× 53 0.4× 98 0.8× 32 691
Licinio Contu Italy 16 304 1.1× 129 0.7× 182 1.3× 95 0.7× 143 1.1× 29 860
Alex So United Kingdom 11 389 1.4× 167 0.9× 92 0.7× 110 0.8× 103 0.8× 14 846
H. Makni Tunisia 14 269 0.9× 118 0.6× 109 0.8× 82 0.6× 59 0.5× 51 692
Ren Zhu France 9 668 2.3× 173 0.9× 81 0.6× 80 0.6× 45 0.4× 15 853
Laura Horváth Hungary 10 276 1.0× 131 0.7× 80 0.6× 167 1.2× 45 0.4× 18 656
Imen Sfar Tunisia 16 251 0.9× 111 0.6× 134 1.0× 124 0.9× 57 0.5× 80 628
S. F. Goldmann Germany 13 469 1.6× 148 0.8× 89 0.6× 113 0.8× 278 2.2× 54 863
A D Levine United States 11 410 1.4× 233 1.2× 180 1.3× 167 1.2× 51 0.4× 19 856
Marina Deschamps France 17 445 1.5× 136 0.7× 136 1.0× 217 1.6× 109 0.9× 39 968

Countries citing papers authored by Chen‐Chung Chu

Since Specialization
Citations

This map shows the geographic impact of Chen‐Chung Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen‐Chung Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen‐Chung Chu more than expected).

Fields of papers citing papers by Chen‐Chung Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen‐Chung Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen‐Chung Chu. The network helps show where Chen‐Chung Chu may publish in the future.

Co-authorship network of co-authors of Chen‐Chung Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Chen‐Chung Chu. A scholar is included among the top collaborators of Chen‐Chung Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen‐Chung Chu. Chen‐Chung Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Yann‐Jinn, Wei‐Hsin Ting, Cheng‐Jui Lin, et al.. (2020). HLA‐DQ genotype and biochemical characterization of anti‐transglutaminase 2 antibodies in patients with type 1 diabetes mellitus in Taiwan. The FASEB Journal. 34(6). 8459–8474. 3 indexed citations
2.
Wang, Liyu, et al.. (2019). Response to hepatitis B vaccination is co-determined by HLA-DPA1 and -DPB1. Vaccine. 37(43). 6435–6440. 10 indexed citations
3.
Chen, Pei‐Lung, Shyang‐Rong Shih, Pei‐Wen Wang, et al.. (2015). Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study. Nature Communications. 6(1). 7633–7633. 74 indexed citations
4.
Hsieh, Ai‐Ru, Su‐Wei Chang, Pei‐Lung Chen, et al.. (2014). Predicting HLA genotypes using unphased and flanking single-nucleotide polymorphisms in Han Chinese population. BMC Genomics. 15(1). 81–81. 10 indexed citations
5.
Wu, Tzu‐Wei, et al.. (2014). SNP rs7770370 in HLADPB1 loci as a major genetic determinant of response to booster hepatitis B vaccination: Results of a genome‐wide association study. Journal of Gastroenterology and Hepatology. 30(5). 891–899. 22 indexed citations
7.
Chen, Pei‐Lung, Cathy S.J. Fann, Chen‐Chung Chu, et al.. (2011). Comprehensive Genotyping in Two Homogeneous Graves' Disease Samples Reveals Major and Novel HLA Association Alleles. PLoS ONE. 6(1). e16635–e16635. 57 indexed citations
8.
Chu, Chen‐Chung, et al.. (2010). Association of HLA-DRB1*0405 with resistance to multibacillary leprosy in Taiwanese. Human Immunology. 71(7). 712–716. 11 indexed citations
9.
Lai, Yuen-Liang, et al.. (2009). Immune impairment in patients with terminal cancers: influence of cancer treatments and cytomegalovirus infection. Cancer Immunology Immunotherapy. 59(2). 323–334. 28 indexed citations
10.
Chu, Chen‐Chung, et al.. (2009). Primary autoimmune neutropenia in children in Taiwan. Transfusion. 49(5). 1003–1006. 16 indexed citations
11.
Huang, Chi‐Yu, Fu‐Sung Lo, Ya‐Ting Chang, et al.. (2008). Association of CT60 Polymorphism of the CTLA4 Gene with Graves' Disease in Taiwanese Children. Journal of Pediatric Endocrinology and Metabolism. 21(7). 665–72. 14 indexed citations
12.
Huang, Chao, Tzu‐Yang Chang, Ming‐Ren Chen, et al.. (2008). Lack of Association of the Vascular Endothelial Growth Factor Gene Polymorphisms with Kawasaki Disease in Taiwanese Children. Journal of Clinical Immunology. 28(4). 322–328. 12 indexed citations
13.
Huang, Chao, Tzu‐Yang Chang, Ming‐Ren Chen, et al.. (2008). Genetic Polymorphisms in the CD40 Ligand Gene and Kawasaki Disease. Journal of Clinical Immunology. 28(5). 405–410. 23 indexed citations
14.
Su, Tsung-Hsien, Tzu‐Yang Chang, Yann‐Jinn Lee, et al.. (2007). CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women. Carcinogenesis. 28(6). 1237–1240. 72 indexed citations
15.
Huang, Chao, Tzu‐Yang Chang, Ming‐Ren Chen, et al.. (2007). The −590 C/T and 8375 A/G interleukin-4 polymorphisms are not associated with Kawasaki disease in Taiwanese children. Human Immunology. 69(1). 52–57. 14 indexed citations
16.
Tsao, Yeou‐Ping, Jianyu Lin, Jia‐Tsrong Jan, et al.. (2006). HLA-A∗0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins. Biochemical and Biophysical Research Communications. 344(1). 63–71. 45 indexed citations
17.
Yang, Yuh‐Cheng, Tzu‐Yang Chang, Yann‐Jinn Lee, et al.. (2006). HLA-DRB1 Alleles and Cervical Squamous Cell Carcinoma: Experimental Study and Meta-Analysis. Human Immunology. 67(4-5). 331–340. 31 indexed citations
18.
Chen, Chia-Ching, Chi‐Yu Huang, Chao Huang, et al.. (2005). The CBLB Gene and Graves' Disease in Children. Journal of Pediatric Endocrinology and Metabolism. 18(11). 1119–26. 3 indexed citations
19.
Chu, Chen‐Chung, et al.. (2001). The use of genotyping to predict the phenotypes of human platelet antigens 1 through 5 and of neutrophil antigens in Taiwan. Transfusion. 41(12). 1553–1558. 20 indexed citations
20.
Chu, Chen‐Chung, et al.. (1999). A Newly Identified Nonsecretor Allele of the Human Histo–Blood Group α(1,2)Fucosyltransferase Gene (FUT2). Vox Sanguinis. 76(2). 115–119. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026